We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.

CHINA MESALAZINE MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2022 - 2030)

China Mesalazine Market, by Route of Administration (Oral and Rectal), by Application (Ulcerative Colitis, Crohn's Disease, and Inflammatory Bowel Disease), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Published In: 25 Nov, 2022
Code: CMI5371
Page number: 102
Formats: Excel and PDF
Industry: Pharmaceutical

Table of Contents (Version-2026)

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snapshot, By Route of Administration
  - Market Snapshot, By Application
  - Market Snapshot, By Distribution Channel
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
  - Restraints
  - Market Opportunities
  - Market Trends
- Epidemiology
- Recent Developments
- Acquisitions and Partnerships Scenario
- Regulatory Scenario
- Pricing Analysis
- PEST Analysis
- Key Highlights
China Mesalazine Market- Impact of Coronavirus (Covid-19) Pandemic
- Overall Impact
- Impact on Supply and Demand
- COVID-19 Impact on the market
China Mesalazine Market, By Route of Administration, 2017 – 2030, (US$ Million)
- Overview
  - Market Share Analysis, 2022 and 2030 (%)
  - Y-o-Y Growth Analysis, 2017 – 2030
  - Segment Trends
- Oral
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Rectal
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
China Mesalazine Market, By Application, 2017 – 2030, (US$ Million)
- Overview
  - Market Share Analysis, 2022 and 2030 (%)
  - Y-o-Y Growth Analysis, 2017 – 2030
  - Segment Trends
- Ulcerative Colitis
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Crohn's Disease
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Inflammatory Bowel Disease
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
China Mesalazine Market, By Distribution Channel, 2017 – 2030, (US$ Million)
- Overview
  - Market Share Analysis, 2022 and 2030 (%)
  - Y-o-Y Growth Analysis, 2017 – 2030
  - Segment Trends
- Hospital Pharmacies
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Retail Pharmacies
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Online Pharmacies
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
Competitive Landscape
- Zhejiang Hengkang Pharmaceutical Co. Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Jiangsu Jubang Pharmaceutical Co., Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- ALP Pharm Beijing Co., Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Shanghai Pharmaceuticals Holding Co Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Heilongjiang Tianhong Pharmaceutical Co., Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- AbbVie Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- F. Hoffmann-La Roche AG
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Takeda Pharmaceuticals Company Limited
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- GSK Plc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Tillotts Pharma AG
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Novartis AG
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Salix Pharmaceuticals
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- FERRING B.V.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Viatris Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Falk Pharma GmbH
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
Section
- Research Methodology
- About Us

*Browse 9 market data tables and 16 figures on "China Mesalazine Market” - forecast to 2030

Get Instant Access - Buy Now

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now